As of 2025-11-09, the Intrinsic Value of Evelo Biosciences Inc (EVLO) is -17.35 USD. This EVLO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Evelo Biosciences Inc is -4,337,887.50%.
Based on its market price of 0.00 USD and our intrinsic valuation, Evelo Biosciences Inc (EVLO) is overvalued by 4,337,887.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.35 - -17.35 | -17.35 | -4,337,887.50% |
| P/E | (24.85) - (43.66) | (32.79) | -8198530.1% |
| DDM - Stable | (0.01) - (0.03) | (0.02) | -5635.0% |
| DDM - Multi | (0.02) - (0.03) | (0.02) | -5372.4% |
| Market Cap (mil) | 0.01 |
| Beta | 0.16 |
| Outstanding shares (mil) | 23.73 |
| Enterprise Value (mil) | 16.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 14,014.90% |
| Cost of Debt | 5.00% |
| WACC | 8.03% |